Article Details
Retrieved on: 2023-10-17 17:12:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here